Related Experiment Video
Updated: Feb 21, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
Suprachoroidal Bleeding After XEN Gel Implantation
Verena Prokosch-Willing1, Urs Vossmerbaeumer, Esther Hoffmann
1Department of Ophthalmology, University of Mainz Eye Hospital, Mainz, Germany.
A rare case of suprachoroidal bleeding occurred after XEN45 gel stent implantation for glaucoma. This complication resolved spontaneously, highlighting the need for informed consent regarding risks of minimally invasive glaucoma surgery.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Minimally Invasive Glaucoma Surgery (MIGS)
Background:
- Pseudoexfoliation glaucoma requires effective intraocular pressure (IOP) management.
- XEN45 gel stent implantation is a minimally invasive glaucoma surgery option.
- This case explores a rare complication following XEN45 gel stent implantation.
Observation:
- A patient with pseudoexfoliation glaucoma underwent XEN45 gel implantation.
- Postoperatively, the patient initially showed improved IOP and a functioning bleb.
- Suprachoroidal bleeding developed on the second postoperative day.
Findings:
- The suprachoroidal bleeding resolved spontaneously over six weeks.
- The XEN45 gel stent achieved significant IOP reduction.
- This complication, though rare, occurred despite a technically uncomplicated procedure.
Implications:
- Minimally invasive glaucoma surgery aims for safer IOP reduction compared to traditional methods.
- Complication rates after XEN45 gel stent implantation may resemble those of trabeculectomy.
- Informed consent must adequately address potential risks associated with XEN45 gel stent surgery.
More Related Videos
11:06Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care
Published on: November 11, 2022
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021